Literature DB >> 19843906

Variation in event rates in trials of patients with type 2 diabetes.

Bruce M Psaty1, Ross L Prentice.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19843906     DOI： 10.1001/jama.2009.1497

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Drug therapies for the primary prevention of cardiovascular events: trials and errors: 2009 Ancel Keys Memorial Lecture.

Authors:  Bruce M Psaty
Journal:  Circulation       Date:  2010-02-23       Impact factor: 29.690

Review 2.  Novel Anti-glycemic Drugs and Reduction of Cardiovascular Risk in Diabetes: Expectations Realized, Promises Unmet.

Authors:  James H Flory; Jenny K Ukena; James S Floyd
Journal:  Curr Atheroscler Rep       Date:  2016-12       Impact factor: 5.113

3.  Study of Cardiovascular Health Outcomes in the Era of Claims Data: The Cardiovascular Health Study.

Authors:  Bruce M Psaty; Joseph A Delaney; Alice M Arnold; Lesley H Curtis; Annette L Fitzpatrick; Susan R Heckbert; Barbara McKnight; Diane Ives; John S Gottdiener; Lewis H Kuller; W T Longstreth
Journal:  Circulation       Date:  2015-11-04       Impact factor: 29.690

4.  Idealized PPARγ-Based Therapies: Lessons from Bench and Bedside.

Authors:  Angélica Amorim Amato; Francisco de Assis Rocha Neves
Journal:  PPAR Res       Date:  2012-06-14       Impact factor: 4.964

5.  Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies.

Authors:  Lisa Pennells; Stephen Kaptoge; Angela Wood; Mike Sweeting; Xiaohui Zhao; Ian White; Stephen Burgess; Peter Willeit; Thomas Bolton; Karel G M Moons; Yvonne T van der Schouw; Randi Selmer; Kay-Tee Khaw; Vilmundur Gudnason; Gerd Assmann; Philippe Amouyel; Veikko Salomaa; Mika Kivimaki; Børge G Nordestgaard; Michael J Blaha; Lewis H Kuller; Hermann Brenner; Richard F Gillum; Christa Meisinger; Ian Ford; Matthew W Knuiman; Annika Rosengren; Debbie A Lawlor; Henry Völzke; Cyrus Cooper; Alejandro Marín Ibañez; Edoardo Casiglia; Jussi Kauhanen; Jackie A Cooper; Beatriz Rodriguez; Johan Sundström; Elizabeth Barrett-Connor; Rachel Dankner; Paul J Nietert; Karina W Davidson; Robert B Wallace; Dan G Blazer; Cecilia Björkelund; Chiara Donfrancesco; Harlan M Krumholz; Aulikki Nissinen; Barry R Davis; Sean Coady; Peter H Whincup; Torben Jørgensen; Pierre Ducimetiere; Maurizio Trevisan; Gunnar Engström; Carlos J Crespo; Tom W Meade; Marjolein Visser; Daan Kromhout; Stefan Kiechl; Makoto Daimon; Jackie F Price; Agustin Gómez de la Cámara; J Wouter Jukema; Benoît Lamarche; Altan Onat; Leon A Simons; Maryam Kavousi; Yoav Ben-Shlomo; John Gallacher; Jacqueline M Dekker; Hisatomi Arima; Nawar Shara; Robert W Tipping; Ronan Roussel; Eric J Brunner; Wolfgang Koenig; Masaru Sakurai; Jelena Pavlovic; Ron T Gansevoort; Dorothea Nagel; Uri Goldbourt; Elizabeth L M Barr; Luigi Palmieri; Inger Njølstad; Shinichi Sato; W M Monique Verschuren; Cherian V Varghese; Ian Graham; Oyere Onuma; Philip Greenland; Mark Woodward; Majid Ezzati; Bruce M Psaty; Naveed Sattar; Rod Jackson; Paul M Ridker; Nancy R Cook; Ralph B D'Agostino; Simon G Thompson; John Danesh; Emanuele Di Angelantonio
Journal:  Eur Heart J       Date:  2019-02-14       Impact factor: 29.983

6.  Cardiovascular and mortality events in type 2 diabetes cardiovascular outcomes trials: a systematic review with trend analysis.

Authors:  Lorenzo M Vetrone; Francesco Zaccardi; David R Webb; Sam Seidu; Nitin N Gholap; Dario Pitocco; Melanie J Davies; Kamlesh Khunti
Journal:  Acta Diabetol       Date:  2018-11-19       Impact factor: 4.280
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.